Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

CONFIRMATORY ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND 2 (HIV 1/2) - ANVISA Registration 80020690328

Access comprehensive regulatory information for CONFIRMATORY ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND 2 (HIV 1/2) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80020690328 and manufactured by BIO-RAD. The registration is held by BIO-RAD LABORATORIOS BRASIL LTDA with validity until Sep 01, 2034.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 2 companies making the same product including VIVACHEK BIOTECH (HANGZHOU) CO., LTD., BIO-RAD, and 4 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
2 Competitors
4 Recent Registrations
80020690328
2 Related Devices
Registration Details
ANVISA Registration Number: 80020690328
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

Registration Details

80020690328

25351435823201391

03188198000177

Company Information

BIO-RAD
France
PT: FRANÇA

Dates and Status

Sep 01, 2014

01/09/2034

09/18/2025 19:00:01

Registration Details

80020690328

25351435823201391

03188198000177

Company Information

Dates and Status

Sep 01, 2014

01/09/2034

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "CONFIRMATORY ANTIBODY FOR HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND 2 (HIV 1/2)"